What’s in a name: Agencies struggle to keep up with expanding drug space
With more approved drugs coming through than ever before, the need to avoid confusing names to ensure patient safety is important.

With more approved drugs coming through than ever before, the need to avoid confusing names to ensure patient safety is important.
Boehringer will utilise a generative AI model developed by IBM to discover candidate antibodies.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Japan approves Daiichi Sankyo’s Covid-19 booster vaccine
IGC Pharma signs agreement to adopt AI solutions into drug discovery
Genentech and NVIDIA enter generative AI-powered drug discovery deal
Daiichi Sankyo signs agreement with Japan to supply Covid-19 vaccine